Celltrion says clinical trials show COVID-19 treatment is safe, effective
June 16, 2021 at 08:11 AM EDT
South Korean pharmaceutical company Celltrion announced that its antibody COVID-19 drug Rekirona is safe and effective after global clinical trials.